The global cell expansion market is projected to experience significant growth, reaching US$ 40.1 billion by 2034. This expansion is driven by factors such as the increasing prevalence of chronic diseases, advancements in cell culture techniques, and growing investments in regenerative medicine. Artificial intelligence and machine learning are revolutionizing cell expansion processes, while the shift towards decentralized healthcare and point-of-care treatments is driving the development of portable and user-friendly technologies.